000 01176 a2200337 4500
005 20250515094524.0
264 0 _c20071218
008 200712s 0 0 eng d
022 _a1558-9951
024 7 _a10.1007/s12009-007-0026-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKnox Cartwright, Nathaniel E
245 0 0 _aBranch retinal vein occlusion and fluoxetine.
_h[electronic resource]
260 _bAnnals of ophthalmology (Skokie, Ill.)
_c2007
300 _a253-4 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aFemale
650 0 4 _aFluoxetine
_xadverse effects
650 0 4 _aFundus Oculi
650 0 4 _aHumans
650 0 4 _aHypertension
_xchemically induced
650 0 4 _aRetinal Vein Occlusion
_xcomplications
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadverse effects
650 0 4 _aVision Disorders
_xetiology
650 0 4 _aVisual Acuity
700 1 _aSmith, P
700 1 _aTole, D M
773 0 _tAnnals of ophthalmology (Skokie, Ill.)
_gvol. 39
_gno. 3
_gp. 253-4
856 4 0 _uhttps://doi.org/10.1007/s12009-007-0026-5
_zAvailable from publisher's website
999 _c17541787
_d17541787